EMERRES Tablet Ref.[7742] Active ingredients: Levonorgestrel

For oral administration: One tablet should be taken, as soon as possible, preferably within 12 hours, and no later than 72 hours after unprotected intercourse (see section 5.1).

If vomiting occurs within three hours of taking the tablet, another tablet should be taken immediately.

Levonorgestrel can be used at any time during the menstrual cycle unless menstrual bleeding is overdue.

After using emergency contraception it is recommended to use a local barrier method (e.g. condom, diaphragm, spermicide, cervical cap) until the next menstrual period starts. The use of levonorgestrel does not contraindicate the continuation of regular hormonal contraception.

Women who have used enzyme-inducing drugs during the last 4 weeks and need emergency contraception are recommended to use a non-hormonal EC, i.e. Cu-IUD or take a double dose of levonorgestrel (i.e. 2 tablets taken together) for those women unable or unwilling to use Cu-IUD (see section 4.5).

Paediatric population

Levonorgestrel is not recommended in children. Very limited data are available in women under 16 years of age.

There is no relevant use of Emerres for children of prepubertal age in the indication emergency contraception.

Serious undesirable effects have not been reported following acute ingestion of large doses of oral contraceptives. Overdose may cause nausea, and withdrawal bleeding may occur. There are no specific antidotes and treatment should be symptomatic.

3 years.

This medicinal product does not require any special storage conditions.

Blister composed of PVC film coated with PVDC and aluminium foil.

Pack size: 1 tablet.

No special requirements. Any unused medicinal product or waste material should be disposed of in accordance with local requirements.